Jane Street
EVOK

Jane Street’s Evoke Pharma EVOK Stock Holding History

Jane Street’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-103
Closed -$8K – 10470
2021
Q4 		$8K Buy
+103
New +$14.4K ﹤0.01% 9920
2021
Q2 		– Sell
-125
Closed -$33K – 9924
2021
Q1 		$33K Buy
+125
New +$50K ﹤0.01% 8912
2019
Q4 		– Sell
-87
Closed -$11K – 5220
2019
Q3 		$11K Buy
+87
New +$11.7K ﹤0.01% 4967
2019
Q2 		– Sell
-74
Closed -$16K – 5274
2019
Q1 		$16K Buy
+74
New +$25.2K ﹤0.01% 4908

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
WA
Wambolt & Associates Littleton, Colorado $297M AUM 17.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street's EVOK Position: Q1 2022 in Review

Jane Street sold out of Evoke Pharma (EVOK) in Q1 2022, closing a stake of 103 shares — an estimated $8K sold.

Jane Street first reported a position in EVOK in Q1 2019 and held it in 4 quarters. The position peaked at $33K in Q1 2021. 20 funds tracked by Wall St. Rank hold EVOK as of Q1 2022.

  • Jane Street reported no remaining Evoke Pharma position as of Q1 2022 after selling out during the quarter.
  • Jane Street sold 103 Evoke Pharma shares in Q1 2022, an estimated $8K.
  • Jane Street first reported a position in Evoke Pharma in Q1 2019 and held it in 4 quarters.
  • Jane Street's Evoke Pharma position peaked at $33K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held Evoke Pharma as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.